Year in Review: COPD 2020

Inhaled Corticosteroid Therapy May Reduce Lung Function Decline in COPD

By

Madeline Morr

The adjusted rate of decline in predose trough FEV1 during 52 weeks in theResearchers used a substudy of the Phase 3 ETHOS study to evaluate lung function decline in patients with inhaled corticosteroid-containing therapies vs glycopyrrolate/formoterol fumarate metered dose inhaler.

COVID-19 With COPD: Fewer Hospitalizations, But Greater Mortality

By

Bill Kekevian

Chronic obstructive pulmonary disease may be associated with higher rates of mortality in patients with coronavirus disease 2019.

HRRP Implementation Reduced 30-Day All-Cause Readmission Rates in COPD

By

Sheila Jacobs

Implementation of the Hospital Readmission Reduction Program was associated with a decrease in 30-day readmissions in patients with COPD following their hospital discharge.

Acute COPD Exacerbation Frequency May Not Be Accurate Guide for Treatment

By

Bryant Moeller

The 12-month history of acute exacerbations used to guide most COPD treatment relies on an unstable frequent exacerbator phenotype.

Electronic Communication From Pulmonologist to PCP Beneficial in COPD Care

By

Madeline Morr

Preemptive, patient-specific electronic messages from pulmonologists to primary care physicians improved guideline concordant care in COPD.